Tackling Thyroid Cancer in Europe-The Challenges and Opportunities

• Tipo: Artigo em Revista Científica Internacional
• Data: 2022

Autores

Horgan, D (Autor) Outra; Fuhrer Sakel, D (Autor) Outra; Soares, P (Autor) FMUP; Alvarez, CV (Autor) Outra; Fugazzola, L (Autor) Outra; Netea Maier, RT (Autor) Outra; Jarzab, B (Autor) Outra; Kozaric, M (Autor) Outra; Bartes, B (Autor) Outra; Schuster Bruce, J (Autor) Outra; Dal Maso, L (Autor) Outra; Schlumberger, M (Autor) Outra; Pacini, F (Autor) Outra

Revista

Título: Healthcare

Vol. 10

Página Final: 1621

Editora: MDPI

Indexação

ISI Web of Knowledge - 4 Citações

Scopus - 7 Citações

Outras Informações

ID Authenticus: P-00X-8R8

DOI: 10.3390/healthcare10091621

Abstract (EN): Thyroid cancer (TC) is the most common malignancy of the endocrine system that affects the thyroid gland. It is usually treatable and, in most cases, curable. The central issues are how to improve knowledge on TC, to accurately identify cases at an early stage that can benefit from effective intervention, optimise therapy, and reduce the risk of overdiagnosis and unnecessary treatment. Questions remain about management, about treating all patients in referral centres, and about which treatment should be proposed to any individual patient and how this can be optimised. The European Alliance for Personalised Medicine (EAPM) hosted an expert panel discussion to elucidate some of the challenges, and to identify possible steps towards effective responses at the EU and member state level, particularly in the context of the opportunities in the European Union's evolving initiatives-notably its Beating Cancer Plan, its Cancer Mission, and its research funding programmes. Recommendations emerging from the panel focus on improved infrastructure and funding, and on promoting multi-stakeholder collaboration between national and European initiatives to complement, support, and mutually reinforce efforts to improve patient care.

Idioma: Inglês

Tipo (Avaliação Docente): Científica

Nº de páginas: 13